Previous 10 | Next 10 |
home / stock / gvdny / gvdny news
Summary Amyris is on the cusp of closing a record strategic transaction slated to generate ~$500mm in cash value. All indications point to a transaction closing in the next two to three weeks. Cash balances by year-end projected to be >$350mm after the strategic transaction close...
Summary M&A and new partnerships are key supportive catalysts to monitor. Givaudan has the pricing power to offset raw material inflationary pressure; however, Symrise's better integration at cost provides less volatility on margins. We are confident that Symrise offers a ...
Givaudan's (GVDBF) Q2 2022 Earnings Conference Call July 21, 2022 9:00 AM ET Company Participants Gilles Andrier - Chief Executive Officer Tom Hallam - Chief Financial Officer Conference Call Participants Heidi Vesterinen - EXANE BNP Paribas Charles E...
Givaudan SA press release ( OTCPK:GVDBF ): 1H GAAP EPS of CHF47.74. Revenue of CHF3.65B (+8.3% Y/Y). For further details see: Givaudan SA GAAP EPS of CHF47.74, revenue of CHF3.65B
The following slide deck was published by Givaudan SA in conjunction with their 2022 Q2 earnings call. For further details see: Givaudan SA 2022 Q2 - Results - Earnings Call Presentation
EATV, the World's First Plant-based Innovation ETF, Makes History at The New York Stock Exchange (NYSE: EATV) PR Newswire VegTech™ Invest, Advisor to EAT V , the V egTech™ Plant-based Innovation & Climate ...
International Flavors & Fragrances has done really well for itself in recent years. The future for the business will also very likely look great for shareholders based on what data we see today. However, shares do look to be more or less fairly valued at this time. For f...
Solid results reported in 2021. Actively capitalizing on emerging trends and long-term opportunities. Risks due to rising competition. For further details see: Givaudan: Medium-Term Prospects But Potential Risks
Givaudan could grow its top and bottom line with a solid pace in fiscal 2021. The company also increased the dividend once again. Despite the stock price decline, Givaudan is still overvalued and not a good investment in my opinion. For further details see: Givaudan: Sto...
VegTech™ Invest Launches the VegTech™ Plant-based Innovation & Alternative Proteins Index VegTech™ Invest Launches the VegTech™ Plant-based Innovation & Alternative Proteins Index PR Newswire Calculated and Distributed by Morning...
News, Short Squeeze, Breakout and More Instantly...
Givaudan AG ADR Company Name:
GVDNY Stock Symbol:
OTCMKTS Market:
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...
Usinas Siderurgicas De Minas Gerais S.A. ADR (Representing Pref Share Cl A) (USNZY) is expected to report $0 for Q2 2024 CREATD INC. (CRTD) is expected to report for Q1 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Senstar Technologie...
Verbund AG ADR (OEZVY) is expected to report for Q1 2024 Rent the Runway Inc. (RENT) is expected to report $-6.56 for Q1 2025 Johnson Matthey plc ADR (JMPLY) is expected to report for Q4 2024 RVL Pharmaceuticals plc (RVLPQ) is expected to report for Q1 2024 Ciena Corporation (CIEN...